Using Machine-Learning Techniques to Identify Responders vs. Non-responders in Randomized Clinical Trials
Vasiliki Nikolodimou, Paul Agapow
doi: https://doi.org/10.1101/2020.11.21.20232041
Vasiliki Nikolodimou
1Health Data Analytics & ML, Imperial College London
Paul Agapow
2Oncology R&D, ML&AI, AstraZeneca UK Ltd
Data Availability
The data used for the conduct of this research is available through DataSphere portal.
Posted November 23, 2020.
Using Machine-Learning Techniques to Identify Responders vs. Non-responders in Randomized Clinical Trials
Vasiliki Nikolodimou, Paul Agapow
medRxiv 2020.11.21.20232041; doi: https://doi.org/10.1101/2020.11.21.20232041
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)